[Federal Register Volume 86, Number 100 (Wednesday, May 26, 2021)]
[Notices]
[Pages 28405-28407]
[FR Doc No: 2021-11077]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-91959; File No. SR-FINRA-2021-011]

Self-Regulatory Organizations; Financial Industry Regulatory
Authority, Inc.; Notice of Filing of a Proposed Rule Change To Amend
FINRA Rule 1011(p) (``Specified Risk Event'')

May 20, 2021.
    Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934
(``Act'') \1\ and Rule 19b-4 thereunder,\2\ notice is hereby given that
on May 12, 2021, the Financial Industry Regulatory Authority, Inc.
(``FINRA'') filed with the Securities and Exchange Commission (``SEC''
or ``Commission'') the proposed rule change as described in Items I,
II, and III below, which Items have been prepared by FINRA. The
Commission is publishing this notice to solicit comments on the
proposed rule change from interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    FINRA is proposing to amend FINRA Rule 1011(p) (``specified risk
event''), to correct an inadvertent drafting error and clarify the
``final regulatory actions'' that are included in the ``specified risk
event'' definition for purposes of the Rule 1000 Series (Member
Application and Associated Person Registration). Rule 1011(p) was among
the rules approved in File No. SR-FINRA-2020-011.\3\
---------------------------------------------------------------------------

    \3\ See Securities Exchange Act Release No. 90635 (December 10,
2020), 85 FR 81540 (December 16, 2020) (Order Approving File No. SR-
FINRA-2020-011) (``SEC Order''). FINRA announced the effective dates
of the rule change in Regulatory Notice 21-09 (March 2021).
---------------------------------------------------------------------------

    Below is the text of the proposed rule change. Proposed new
language is in italics; proposed deletions are in brackets.
* * * * *

FINRA Rules

* * * * *

1000. MEMBER APPLICATION AND ASSOCIATED PERSON REGISTRATION

* * * * *

1011. Definitions

    Unless otherwise provided, terms used in the Rule 1000 Series shall
have the meaning as defined in Rule 0160.

(a) through (o) No Change.

    (p) ``specified risk event''
    The term ``specified risk event'' means any one of the following
events that are disclosed, or are or were required to be disclosed, on
an applicable Uniform Registration Form:
    (1) through (3) No Change.
    (4) a final regulatory action where: (A) the total monetary
sanctions (including civil and administrative penalties or fines,
disgorgement, monetary penalties other than fines, or restitution) were
ordered for a dollar amount at or above $15,000; or (B) the sanction
against the person was a bar (permanently or temporarily), expulsion,
rescission, revocation, or suspension[ from associating with a member].
    (q) through (r) No Change.
* * * * *

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, FINRA included statements
concerning the purpose of and basis for the proposed rule change and
discussed any comments it received on the proposed rule change. The
text of these statements may be examined at the places specified in
Item IV below. FINRA has prepared summaries, set forth in sections A,
B, and C below, of the most significant aspects of such statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

1. Purpose
    On December 10, 2020, the Commission approved a proposed rule
change concerning brokers with a significant history of misconduct.\4\
The SEC Order approved, in pertinent part, the amendment of the Rule
1000 Series (Member Application and Associated Person Registration) to
require a member firm to submit a written request to FINRA's Department
of Member Regulation (``Member Regulation''), through the Membership
Application Group (``MAP Group''), seeking a materiality consultation
and approval of a continuing membership application, if required, when
a natural person seeking to become an owner, control person, principal,
or registered person of the member broker-dealer has, in the prior five
years, one or more ``final criminal matters'' or two or more
``specified risk events.'' \5\ The amendments to the Rule 1000 Series
will become effective on September 1, 2021.\6\
---------------------------------------------------------------------------

    \4\ See SEC Order, supra note 3.
    \5\ See SEC Order, supra note 3, at 81541.
    \6\ See Regulatory Notice 21-09 (March 2021).
---------------------------------------------------------------------------

    The rules approved in the SEC Order relating to SR-FINRA-2020-011
included Rule 1011(p), which defines ``specified risk event'' to mean
``any one of the . . . events'' described in Rule 1011(p) ``that are
disclosed, or are or were required to be disclosed, on an applicable
Uniform Registration Form.'' The events described in Rule 1011(p)
include, among others, a ``final regulatory action'' as set forth in
Rule 1011(p)(4). Specifically, Rule 1011(p)(4) describes ``a final
regulatory action'' to include final regulatory actions ``where (A) the
total monetary sanctions (including civil and administrative penalties
or fines, disgorgement, monetary penalties other than fines, or
restitution) were ordered for a dollar amount at or above $15,000; or
(B) the sanction against the person was a bar (permanently or
temporarily), expulsion, rescission, revocation, or suspension from
associating with a member.''
    The proposed rule change would delete from Rule 1011(p)(4) the
phrase ``from associating with a member,'' which appears after the word
``suspension.'' Including ``from associating with a member'' in Rule
1011(p)(4) was an inadvertent drafting error that may suggest
incorrectly that it narrows the ``final regulatory actions'' that are
included in the ``specified risk event'' definition. For example, the
current rule text may suggest that the ``specified risk event''
definition does not include final SEC and CFTC regulatory actions where
the sanction against the person was a suspension other than a
suspension from associating with a member.
    However, as evidenced by other provisions in Rule 1011(p), FINRA
did not intend to narrow the scope of ``final regulatory actions'' that
are included in the ``specified risk event'' definition in this manner.
Rule 1011(p)(4) is intended to be consistent with Rule 1011(p)(3),
which describes the ``final investment-related civil actions'' that are
included in the ``specified risk event'' definition. Rule 1011(p)(3)
includes final investment-related civil actions that result in a
``suspension,'' and does not limit the suspensions to suspensions from
associating with a member. Moreover, FINRA's intent to include ``final
regulatory actions'' beyond those resulting in suspensions ``from
associating with a member'' in the ``specified risk event'' definition
is further evidenced by the mapping exhibits that FINRA provided in SR-
FINRA-2020-011, which showed how the ``final regulatory actions''
included within the scope of the ``specified risk event'' definition
included final regulatory actions disclosed on the Uniform Registration
Forms that resulted in a ``suspension.'' \7\ Those mapping exhibits, in
turn, were and are consistent with how the relevant sanctions-related
questions on the Uniform Registration Forms require the reporting of
regulatory actions initiated by numerous regulators and self-regulatory
organizations--not just FINRA--and include data fields for
``suspension.'' \8\ By correcting the inadvertent drafting error and
clarifying the ``final regulatory actions'' that are included in the
``specified risk event'' definition, the proposed rule change will
ensure that the rules approved in SR-FINRA-2020-011 fully serve their
intended investor-protection purposes.\9\
---------------------------------------------------------------------------

    \7\ See Form 19b-4, Exs. 3a and 3b, File No. SR-FINRA-2020-011,
available at https://www.finra.org/sites/default/files/2020-04/SR-FINRA-2020-011.pdf.
    \8\ See Uniform Application for Securities Industry Registration
or Transfer (Form U4), Regulatory Action Disclosure Reporting Page,
Questions 1 (requesting information about which regulator initiated
the regulatory action) and 13 (Sanction Detail); Uniform Application
for Broker-Dealer Registration (Form BD), Regulatory Action
Disclosure Reporting Page, Part II, Questions 1 (requesting
information about which regulator initiated the regulatory action)
and Question 2 (Principal Sanction). FINRA also notes that the data
that FINRA provided in SR-FINRA-2020-011 concerning the regulatory
action disclosures included regulatory actions that resulted in any
suspension, not just suspensions from associating with a member.
    \9\ See SEC Order, supra note 3, at 81546 (explaining that the
rules approved in SR-FINRA-2020-011 ``further promote investor
protection by applying additional safeguards and disclosure
obligations for a broker-dealer's continuing membership with FINRA
and for changes to a current member broker-dealer's ownership,
control, or business operations,'' where those changes involve
persons with a significant history of misconduct).
---------------------------------------------------------------------------

    If the Commission approves the proposed rule change, FINRA expects
that the effective date will be September 1, 2021, the same effective
date for the amendments to Rule 1000 Series that FINRA announced in
Regulatory Notice 21-09.\10\
---------------------------------------------------------------------------

    \10\ FINRA notes that the proposed rule change would apply to
all members, including members that have elected to be treated as
capital acquisition brokers (``CABs''), given that the CAB rule set
incorporates FINRA Rule 1011 by reference.
---------------------------------------------------------------------------

2. Statutory Basis
    FINRA believes that the proposed rule change is consistent with the
provisions of Section 15A(b)(6) of the Act,\11\ which requires, among
other things, that FINRA rules must be designed to prevent fraudulent
and manipulative

acts and practices, to promote just and equitable principles of trade,
and, in general, to protect investors and the public interest. FINRA
believes that, by amending Rule 1011(p)(4) to correct an inadvertent
drafting error, and fully and accurately describe the ``final
regulatory actions'' that the definition of ``specified risk event''
includes, the proposed rule change will provide greater clarity to
members and the public and serve the intended investor-protection
purposes of the rules approved in SR-FINRA-2020-011.
---------------------------------------------------------------------------

    \11\ 15 U.S.C. 78o-3(b)(6).
---------------------------------------------------------------------------

B. Self-Regulatory Organization's Statement on Burden on Competition

    FINRA does not believe that the proposed rule change is associated
with any material economic impacts or will result in any burden on
competition that is not necessary or appropriate in furtherance of the
purposes of the Act. The proposed rule change is not designed to
address any competitive issues but rather to correct an inadvertent
drafting error in Rule 1011(p)(4) that resulted in a narrower scope for
the ``final regulatory actions'' that are included in the ``specified
risk event'' definition than FINRA intended.
    The aspect of the economic impact assessment undertaken in File No.
SR-FINRA-2020-011 that pertained to the amendments to the Rule 1000
Series was based on the broader scope for the ``final regulatory
actions'' that are included in the ``specified risk event'' definition
that FINRA is proposing here. Consistent with FINRA's initial intent,
the broader scope for the ``final regulatory actions'' that are
included in the ``specified risk event'' definition includes, for
example, final SEC and CFTC regulatory actions where the sanction
against the person was a suspension other than a suspension from
associating with a member.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants, or Others

    Written comments were neither solicited nor received.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    Within 45 days of the date of publication of this notice in the
Federal Register or within such longer period (i) as the Commission may
designate up to 90 days of such date if it finds such longer period to
be appropriate and publishes its reasons for so finding or (ii) as to
which the self-regulatory organization consents, the Commission will:
    (A) By order approve or disapprove such proposed rule change, or
    (B) institute proceedings to determine whether the proposed rule
change should be disapproved.

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's internet comment form (http://www.sec.gov/rules/sro.shtml); or
     Send an email to<EMAIL_ADDRESS>Please include
File Number SR-FINRA-2021-011 on the subject line.

Paper Comments

     Send paper comments in triplicate to Secretary, Securities
and Exchange Commission, 100 F Street NE, Washington, DC 20549-1090.

All submissions should refer to File Number SR-FINRA-2021-011. This
file number should be included on the subject line if e-mail is used.
To help the Commission process and review your comments more
efficiently, please use only one method. The Commission will post all
comments on the Commission's internet website (http://www.sec.gov/rules/sro.shtml). Copies of the submission, all subsequent amendments,
all written statements with respect to the proposed rule change that
are filed with the Commission, and all written communications relating
to the proposed rule change between the Commission and any person,
other than those that may be withheld from the public in accordance
with the provisions of 5 U.S.C. 552, will be available for website
viewing and printing in the Commission's Public Reference Room, 100 F
Street NE, Washington, DC 20549, on official business days between the
hours of 10 a.m. and 3 p.m. Copies of such filing also will be
available for inspection and copying at the principal office of FINRA.
All comments received will be posted without change. Persons submitting
comments are cautioned that we do not redact or edit personal
identifying information from comment submissions. You should submit
only information that you wish to make available publicly.
    All submissions should refer to File Number SR-FINRA-2021-011 and
should be submitted on or before June 16, 2021.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\12\
---------------------------------------------------------------------------

    \12\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

J. Matthew DeLesDernier,
Assistant Secretary.
[FR Doc. 2021-11077 Filed 5-25-21; 8:45 am]
BILLING CODE 8011-01-P


[Federal Register Volume 80, Number 57 (Wednesday, March 25, 2015)]
[Notices]
[Page 15778]
[FR Doc No: 2015-06740]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. CP15-113-000]

Questar Pipeline Company; Notice of Request Under Blanket
Authorization

    Take notice that on March 10, 2015, Questar Pipeline Company
(Questar), 333 South State Street, Salt Lake City, Utah 84111, filed in
Docket No. CP15-113-000, a prior notice request pursuant to sections
157.205 and 157.216 of the Commission's regulations under the Natural
Gas Act (NGA)and Questar's blanket authorization issued in Docket No.
CP82-491-000. Questar seeks authorization to abandon, in-place its
Price Dew Point Plant and appurtenant facilities (collectively the
Price DPP or Plant) located in Carbon County, Utah, all as more fully
set forth in the application which is on file with the Commission and
open for public inspection. The filing may also be viewed on the web at
http://www.ferc.gov using the ``eLibrary'' link. Enter the docket
number excluding the last three digits in the docket number field to
access the document. For assistance, contact FERC at
<EMAIL_ADDRESS>or call toll-free,<PHONE_NUMBER> or TTY,
(202) 502-8659.
    Any questions concerning this application may be directed to: L.
Bradley Burton, General Manager, Federal Regulatory Affairs and FERC
Compliance Officer, Questar Pipeline Company, 333 South State Street,
P.O. Box 45360, Salt Lake City, Utah 84145-0360. Mr. Burton also may be
contacted at<PHONE_NUMBER>,<PHONE_NUMBER> (fax) or
<EMAIL_ADDRESS>    Any person may, within 60 days after the issuance of the instant
notice by the Commission, file pursuant to Rule 214 of the Commission's
Procedural Rules (18 CFR 385.214) a motion to intervene or notice of
intervention. Any person filing to intervene or the Commission's staff
may, pursuant to section 157.205 of the Commission's Regulations under
the NGA (18 CFR 157.205) file a protest to the request. If no protest
is filed within the time allowed therefore, the proposed activity shall
be deemed to be authorized effective the day after the time allowed for
protest. If a protest is filed and not withdrawn within 30 days after
the time allowed for filing a protest, the instant request shall be
treated as an application for authorization pursuant to section 7 of
the NGA.
    Pursuant to section 157.9 of the Commission's rules, 18 CFR 157.9,
within 90 days of this Notice the Commission staff will either:
complete its environmental assessment (EA) and place it into the
Commission's public record (eLibrary) for this proceeding; or issue a
Notice of Schedule for Environmental Review. If a Notice of Schedule
for Environmental Review is issued, it will indicate, among other
milestones, the anticipated date for the Commission staff's issuance of
the final environmental impact statement (FEIS) or EA for this
proposal. The filing of the EA in the Commission's public record for
this proceeding or the issuance of a Notice of Schedule for
Environmental Review will serve to notify federal and state agencies of
the timing for the completion of all necessary reviews, and the
subsequent need to complete all federal authorizations within 90 days
of the date of issuance of the Commission staff's FEIS or EA.
    Persons who wish to comment only on the environmental review of
this project should submit an original and two copies of their comments
to the Secretary of the Commission. Environmental commenters will be
placed on the Commission's environmental mailing list, will receive
copies of the environmental documents, and will be notified of meetings
associated with the Commission's environmental review process.
Environmental commenters will not be required to serve copies of filed
documents on all other parties. However, the non-party commenters will
not receive copies of all documents filed by other parties or issued by
the Commission (except for the mailing of environmental documents
issued by the Commission) and will not have the right to seek court
review of the Commission's final order.
    The Commission strongly encourages electronic filings of comments,
protests, and interventions via the internet in lieu of paper. See 18
CFR 385.2001(a)(1)(iii) and the instructions on the Commission's Web
site (www.ferc.gov) under the ``e-Filing'' link. Persons unable to file
electronically should submit an original and 5 copies of the protest or
intervention to the Federal Energy regulatory Commission, 888 First
Street NE., Washington, DC 20426.

     Dated: March 18, 2015.
Kimberly D. Bose,
Secretary.
[FR Doc. 2015-06740 Filed 3-24-15; 8:45 am]
 BILLING CODE 6717-01-P


United States Environmental Protection Agency, Washington, D.C. 20460

DATA CALL-IN RESPONSE	OMB Approval 2070-0174

INSTRUCTIONS: Please type or print in ink.  Please read carefully the attached instructions and supply the information requested on this form.  Use additional sheet(s) if necessary.

1. Company Name and Address

	2. Case # and Name

Mevinphos

    Active Ingredient # and name

    015801 Mevinphos	3. Date and Type of DCI and Number

GENERIC FFDCA DCI

Item 9, enter the appropriate numerical response for each guideline study that you intend to support: 1 = Developing Data, 2 = Submitting an Existing Study, 3 = Upgrading a Study, 4 = Citing an Existing Study.  (For 860.1500 or 860.1520, concerning a specific commodity, you may enter 5 = Will not support).

4. Guideline

Requirement

Number	5. Study title	Footnotes to Data

Requirements	6a. Protocol	6b. Progress Reports	7. Test Substance	8. Time Frame

(Months)	9. Recipient Response

1	2	3

	860.1200	Directions for Use	No

	 ----	12

	860.1500  	Crop Field Trial - Broccoli	Yes

	TEP	24

	860.1500 	Crop Field Trial - Cabbage	Yes

	TEP	24

	860.1500 	Crop Field Trial - Cauliflower	Yes

	TEP	24

	860.1500 	Crop Field Trial - Celery	Yes

	TEP	24

	860.1500 	Crop Field Trial - Grapes	Yes

	TEP	24

	860.1500 	Crop Field Trial - Lettuce	Yes

	TEP	24

	860.1500 	Crop Field Trial - Peas	Yes

	TEP	24

	860.1500 	Crop Field Trial - Peppers	Yes

	TEP	24

	860.1500 	Crop Field Trial - Spinach	Yes

	TEP	24

	860.1500 	Crop Field Trial - Squash, summer	Yes

	TEP	24

	860.1500 	Crop Field Trial - Strawberries	Yes

	TEP	24

	860.1500 	Crop Field Trial - Tomatoes	Yes

	TEP	24

	860.1520 	Processing Study - Tomatoes	Yes

	TEP	24

	870.6300	Comparative Cholinesterase Assay	Yes

	TGAI	12

	870.7800	Immunotoxicity 	No

	TGAI	12

	10. Certification:  I certify that the statements made on this form and all attachments are true, accurate, and complete.  I acknowledge that any knowingly false or misleading statement may be punishable by fine, imprisonment or both under applicable law.

Signature of Individual or Signature and Title of Company’s Authorized Representative _____________________________________________

	11. Date

12. Name of Company or Individual Contact (Include e-mail address)

	13. Phone Number

Failure to Submit the 90-Day Response:

If a submission of a response to U.S. EPA to comply with the Data Call-In requirements of the final order is not submitted within 90 days after publication of the final order in the Federal Register, EPA may revoke the appropriate tolerance or tolerances associated with the active ingredient named in Item 2.

90-Day Response Instructions:

Item 1, enter your company or individual name and address.

Item 6a identifies any study protocol report timeframe, if required by the Agency.

Item 6b identifies study progress report timeframes, if required by the Agency.

Item 7 identifies the code associated with the substance that must be used for testing:

PAI = pure active ingredient, TGAI = technical grade active ingredient, EUP = end-use product, MP = manufacturing-use product, MET = metabolites, TEP = typical end-use product, PAI/M = pure active ingredient and metabolites, TEP/MET = typical end-use product and metabolites, DEGR = degradates, IMP = impurities, PAIRA = pure active ingredient radiolabeled, PAIRA/M = pure active ingredient radiolabeled and metabolites, PAIRA/PM = pure active ingredient radiolabeled and plant metabolites, TGAI/TEP = technical grade active ingredient or typical end-use product, PAI/PAIRA = pure active ingredient or pure active ingredient radiolabeled, MP/TGAI = manufacturing-use product and technical grade active ingredient, TGAI/PAIRA = technical active ingredient or pure active ingredient radiolabeled, TGAI/PAI = technical grade active ingredient or pure active ingredient, TEP/PAI/M = typical end-use product or pure active ingredient and metabolites.

Item 8 identifies timeframes for EPA’s receipt of data. Timeframes begin on the date of publication in the Federal Register of the final order for the Data Call-In.

Item 9, enter the appropriate numerical response for each guideline study that you intend to support: 1 = Developing Data, 2 = Submitting an Existing Study (that has not been submitted previously to EPA by anyone), 3 = Upgrading a Study (classified by EPA as partially acceptable and upgradeable), 4 = Citing an Existing Study (that EPA has classified as acceptable or an existing study that has been submitted but not reviewed by the Agency).  Note, for guidelines 860.1500 or 860.1520, concerning a specific commodity, you may enter 5 = Will not support.

Item 10, sign the certification statement – it must be signed by an authorized representative of your company and the person signing must include his/her title.

Item 11, enter the date of signature.

Item 12, enter the name of the person EPA should contact with questions regarding your response (Include e-mail address).

Item 13, enter the telephone number of your company contact.

Failure to Comply with Response Commitment and/or Data Requirements:

Events that may be the basis for revocation of tolerances associated with the active ingredient named in Item 2 include, but are not limited to the following:

No person submits on the required schedule: (1) an acceptable proposed or final protocol when such is required to be submitted to the Agency for review, (2) an adequate progress report on a study as required by the final order, (3) acceptable data as required by the final order, (4) supportable certifications as to the conditions of submitted data, where required by the final order and where no other cited or submitted study meets the data requirements the study was intended to fulfill.

United States Environmental Protection Agency, Washington, D.C. 20460

FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTS

Case # and Name    250 Mevinphos, GENERIC FFDCA DCI	OMB Approval 2070-0174

Footnotes:

860.1200	Directions for use

(No footnotes for this study)

860.1500 Crop field trials

1. Required for residential outdoor uses on food crops if the corresponding agricultural use is not approved or the residential use is expected to produce higher residues based on the label directions.

2. A residue method, storage stability data, and crop field trials are required for the nonfood crop tobacco (green, freshly harvested). Depending on the level of residues found on the green tobacco, additional data may be required on cured/dried tobacco and pyrolysis products.

3. Required for indoor uses which are direct postharvest treatments of raw agricultural commodities (e.g., fungicidal axes or stored grain fumigants).

4. Crop field trials are required to establish tolerances on rotational crops when quantifiable residues of concern are observed in the field rotational crops study.

5. Not required for an exemption from a tolerance provided that dietary exposure estimates are not needed due to low toxicity or that theoretical estimates of exposure are adequate to assess dietary risk.

860.1520 Processed food or feed

1. Required if indoor use could result in pesticide residues in or on food or feed.

2. Data on the nature and level of residues in processed food/feed are required if residues could potentially concentrate on processing thus requiring the establishment of a separate tolerance higher than that of the raw agricultural commodity.

3. Not required for an exemption from a tolerance provided that dietary exposure estimates are not needed due to low toxicity or that theoretical estimates of exposure are adequate to assess dietary risk.

870.6300 Developmental neurotoxicity

1. An information-based approach to testing is preferred, which utilizes the best available knowledge on the chemical (hazard, pharmacokinetic, or mechanistic data) to determine whether a standard guideline study, an enhanced guideline study, or an alternative study should be conducted to assess potential hazard to the developing animal, or in some cases to support a waiver for such testing. Registrants should submit any alternative proposed testing protocols and supporting scientific rationale to the Agency prior to study initiation.

2. Study required using a weight-of-evidence approach considering:

(i) The pesticide causes treatment-related neurological effects in adult animal studies (i.e., clinical signs of neurotoxicity, neuropathology, functional  or behavioral effects).

(ii) The pesticide causes treatment-related neurological effects in developing animals, following pre- and postnatal exposure ( i.e. , nervous system malformations or neuropathy, brain weight changes in offspring, functional or behavioral changes in the offspring).

(iii) The pesticide elicits a causative association between exposures and adverse neurological effects in human epidemiological studies.

(iv) The pesticide evokes a mechanism that is associated with adverse effects on the development of the nervous system (e.g., SAR relationship to known neurotoxicants, altered neuroreceptor or neurotransmitter responses).

3. The use of a combined study that utilizes the 2–generation reproduction study in rodents as a basic protocol for the addition of other endpoints or functional assessments in the immature animal is encouraged.

870.7800 Immunotoxicity

(No footnotes for this study)